Menu

Darah focuses her practice on the representation of both underwriters and issuers on a variety of capital markets transactions. Darah also regularly counsels publicly traded companies on general corporate matters, including SEC reporting and corporate governance.

Download full bio 

Experience

  • Karuna Therapeutics – $862.5 Million Follow-on Offering 

  • Verve Therapeutics – $258.8 Million Follow-on Offering 

  • Verve Therapeutics – $258.8 Million Follow-on Offering 

  • Scholar Rock – $205 Million Registered Direct Offering 

  • Apellis Pharmaceuticals – $402.5 Million Follow-On Offering 

  • View all

Practices & Industries

Education

  • University of California Hastings College of Law
    JD, magna cum laude, Order of the Coif, Thurston Society, 2014

  • Emory University
    BA, Political Science and Journalism
    2010


Admissions & Credentials

District of Columbia

California